Literature DB >> 3330518

Comparative in vivo and in vitro metabolism of ivermectin in steers, sheep, swine, and rat.

S H Chiu1, R Taub, E Sestokas, A Y Lu, T A Jacob.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3330518     DOI： 10.3109/03602538708998309

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  9 in total

1.  Lack of sex-influence on the in vitro metabolism of ivermectin by hepatic microsomal preparations from cattle.

Authors:  J Dupuy; C Eeckhoutte; J F Sutra; C Mage; M Alvinerie
Journal:  Vet Res Commun       Date:  1999-06       Impact factor: 2.459

2.  Interspecies considerations in the evaluation of human food safety for veterinary drugs.

Authors:  Arthur L Craigmill; Kristy A Cortright
Journal:  AAPS PharmSci       Date:  2002

3.  In vitro metabolism of 14C-moxidectin by hepatic microsomes from various species.

Authors:  J Dupuy; E Escudero; C Eeckhoutte; J F Sutra; P Galtier; M Alvinerie
Journal:  Vet Res Commun       Date:  2001-07       Impact factor: 2.459

Review 4.  Moxidectin and the avermectins: Consanguinity but not identity.

Authors:  Roger Prichard; Cécile Ménez; Anne Lespine
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-14       Impact factor: 4.077

5.  Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.

Authors:  Carlos J Chaccour; Felix Hammann; Marta Alustiza; Sandra Castejon; Brian B Tarimo; Gloria Abizanda; Ángel Irigoyen Barrio; Helena Martí Soler; Rafael Moncada; José Ignacio Bilbao; Azucena Aldaz; Marta Maia; José Luis Del Pozo
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

6.  Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.

Authors:  Kevin C Kobylinski; Podjanee Jittamala; Borimas Hanboonkunupakarn; Sasithon Pukrittayakamee; Kanchana Pantuwatana; Siriporn Phasomkusolsil; Silas A Davidson; Markus Winterberg; Richard M Hoglund; Mavuto Mukaka; Rob W van der Pluijm; Arjen Dondorp; Nicholas P J Day; Nicholas J White; Joel Tarning
Journal:  Clin Pharmacol Ther       Date:  2019-12-27       Impact factor: 6.875

7.  Identification of the metabolites of ivermectin in humans.

Authors:  Phornpimon Tipthara; Kevin C Kobylinski; Markus Godejohann; Borimas Hanboonkunupakarn; Alison Roth; John H Adams; Nicholas J White; Podjanee Jittamala; Nicholas P J Day; Joel Tarning
Journal:  Pharmacol Res Perspect       Date:  2021-02

8.  Transgenic Expression of Haemonchus contortus Cytochrome P450 Hco-cyp-13A11 Decreases Susceptibility to Particular but Not All Macrocyclic Lactones in the Model Organism Caenorhabditis elegans.

Authors:  Natalie Jakobs; Esra Yilmaz; Jürgen Krücken
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

Review 9.  Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety.

Authors:  Carlos Chaccour; Felix Hammann; N Regina Rabinovich
Journal:  Malar J       Date:  2017-04-24       Impact factor: 2.979
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.